These findings identify PDK1 as a critical mediator of HCC radioresistance through the PI3K/AKT/mTOR pathway, implicating it as a promising therapeutic target to sensitize tumors to radiation and inhibit stemness‐associated traits. This evidence concerns the gene PDK1 and hepatocellular carcinoma.